Scientific article
Review
English

Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery

Published in

The oncologist, vol. 15, no. 4, p. 390-404

Publication date

2010

Abstract

The number of agents that are potentially effective in the adjuvant treatment of locally advanced resectable colon cancer is increasing. Consequently, it is important to ascertain which subgroups of patients will benefit from a specific treatment. Despite more than two decades of research into the molecular genetics of colon cancer, there is a lack of prognostic and predictive molecular biomarkers with proven utility in this setting. A secondary objective of the Pan European Trials in Adjuvant Colon Cancer-3 trial, which compared irinotecan in combination with 5-fluorouracil and leucovorin in the postoperative treatment of stage III and stage II colon cancer patients, was to undertake a translational research study to assess a panel of putative prognostic and predictive markers in a large colon cancer patient cohort. The Cancer and Leukemia Group B 89803 trial, in a similar design, also investigated the use of prognostic and predictive biomarkers in this setting. In this article, the authors, who are coinvestigators from these trials and performed similar investigations of biomarker discovery in the adjuvant treatment of colon cancer, review the current status of biomarker research in this field, drawing on their experiences and considering future strategies for biomarker discovery in the postgenomic era.

Keywords

  • Chemotherapy, Adjuvant
  • Colorectal Neoplasms/ genetics/pathology/therapy
  • Disease Progression
  • Genes, p53/genetics
  • Genomic Instability
  • Genomics
  • Humans
  • Microsatellite Instability
  • Phenotype
  • Predictive Value of Tests
  • Prognosis
  • Proto-Oncogene Proteins/genetics
  • Proto-Oncogene Proteins B-raf/genetics
  • Tumor Markers, Biological
  • Ras Proteins/genetics

Citation (ISO format)

TEJPAR, Sabine et al. Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery. In: The oncologist, 2010, vol. 15, n° 4, p. 390–404. doi: 10.1634/theoncologist.2009-0233

Main files (1)

Article

Identifiers

Additional URL for this publication

http://theoncologist.alphamedpress.org/

Journal ISSN

1083-7159
651views
0downloads

Technical informations

Creation

23/05/2012 08:57:38

First validation

23/05/2012 08:57:38

Update

14/03/2023 17:36:06

Status update

14/03/2023 17:36:05

Last indexation

29/10/2024 20:10:30
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated